Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.1
3.0
Journals
JPM
Special Issues
Biobank and Biorepository in Personalized Medicine
share announcement

Biobank and Biorepository in Personalized Medicine

A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Evidence Based Medicine".

Deadline for manuscript submissions: closed (25 April 2024) | Viewed by 888

Special Issue Editor

Dr. Zisis Kozlakidis

E-Mail Website
Guest Editor
International Agency for Research on Cancer, Lyon, France
Interests: biobanking; infectious diseases; digital health; biomarkers

Special Issue Information

Dear Colleagues,

Biobanks are infrastructures aiming at collecting, processing, storing and distributing biological samples (usually human) and derivative materials for use in research, along with associated data and within defined regulatory frameworks.

Biobanking has become an important resource in medical research, supporting the scaling-up of many types of contemporary research such as genomics and personalized medicine. In recent years, many disease-oriented biobanks have emerged, while tumor biobanks have attracted great interest and funding.

This Special Issue will focus on recent advances in the field of biobanking and biobanking research and its application of novel techniques in the field of personalized medicine. Original articles and reviews highlighting biobanks in disease treatment and personalized medicine are welcome.

Dr. Zisis Kozlakidis
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biobanking
  • infectious diseases
  • digital health
  • biomarkers
  • precision medicine

Published Papers (2 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

11 pages, 910 KiB  
Communication
Data Model for the Comprehensive Management of Biobanks and Its Contribution to Personalized Medicine
by Ana María Sánchez-López, Purificación Catalina, Fernando Franco, Sonia Panadero-Fajardo, Juan David Rejón, María Concepción Romero-Sánchez, Jose Manuel Puerta-Puerta and Rocío Aguilar-Quesada
J. Pers. Med. 2024, 14(7), 668; https://doi.org/10.3390/jpm14070668 - 21 Jun 2024
Viewed by 391
Abstract
Biobanks are infrastructures essential for research involving multi-disciplinary teams and an increasing number of stakeholders. In the field of personalized medicine, biobanks play a key role through the provision of well-characterized and annotated samples protecting at the same time the right of donors. [...] Read more.
Biobanks are infrastructures essential for research involving multi-disciplinary teams and an increasing number of stakeholders. In the field of personalized medicine, biobanks play a key role through the provision of well-characterized and annotated samples protecting at the same time the right of donors. The Andalusian Public Health System Biobank (SSPA Biobank) has implemented a global information management system made up of different modules that allow for the recording, traceability and monitoring of all the information associated with the biobank operations. The data model, designed in a standardized and normalized way according to international initiatives on data harmonization, integrates the information necessary to guarantee the quality of results from research, benefiting researchers, clinicians and donors. Full article
(This article belongs to the Special Issue Biobank and Biorepository in Personalized Medicine)
►▼ Show Figures

Figure 1

Review

Jump to: Research

12 pages, 3138 KiB  
Review
Biobanks as an Indispensable Tool in the “Era” of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma
by Alessandro Valenti, Italia Falcone, Fabio Valenti, Elena Ricciardi, Simona Di Martino, Maria Teresa Maccallini, Marianna Cerro, Flora Desiderio, Ludovica Miseo, Michelangelo Russillo and Antonino Guerrisi
J. Pers. Med. 2024, 14(7), 731; https://doi.org/10.3390/jpm14070731 - 6 Jul 2024
Viewed by 202
Abstract
In recent years, medicine has undergone profound changes, strongly entering a new phase defined as the “era of precision medicine”. In this context, patient clinical management involves various scientific approaches that allow for a comprehensive pathology evaluation: from preventive processes (where applicable) to [...] Read more.
In recent years, medicine has undergone profound changes, strongly entering a new phase defined as the “era of precision medicine”. In this context, patient clinical management involves various scientific approaches that allow for a comprehensive pathology evaluation: from preventive processes (where applicable) to genetic and diagnostic studies. In this scenario, biobanks play an important role and, over the years, have gained increasing prestige, moving from small deposits to large collections of samples of various natures. Disease-oriented biobanks are rapidly developing as they provide useful information for the management of complex diseases, such as melanoma. Indeed, melanoma, given its highly heterogeneous characteristics, is one of the oncologic diseases with the greatest clinical and therapeutic management complexity. So, the possibility of extrapolating tissue, genetic and imaging data from dedicated biobanks could result in more selective study approaches. In this review, we specifically analyze the several biobank types to evaluate their role in technology development, patient monitoring and research of new biomarkers, especially in the melanoma context. Full article
(This article belongs to the Special Issue Biobank and Biorepository in Personalized Medicine)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-2
Back to TopTop